Experience by Service Offering

Integrate Five BioTechs At Once

Integrate Five BioTechs At Once In 2022 KKR invested with Ampersand in Biosynth and four other Biotech companies in Europe and the U.S. to create a platform for a new Life Sciences company The task: Produce and execute a business and technology integration plan for five companies at the same time with four different close dates. This included communications, day 1 planning,

Integrate Five BioTechs At Once Read More »